Jiangxi Tianxin Pharmaceutical Co., Ltd. Class ASSE: 603235

Annual Evaluation Report on the "Corporate Value and Return Enhancement" Action Plan 2025 and the "Corporate Value and Return Enhancement" Action Plan 2026

· Issued by Jiangxi Tianxin Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Annual Evaluation Report on the "Corporate Value and Return Enhancement" Action Plan 2025 and the "Corporate Value and Return Enhancement" Action Plan 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Jiangxi Tianxin Pharmaceutical Co., Ltd. Class A

All Jiangxi Tianxin Pharmaceutical Co., Ltd. Class A news releases